Kistler-Tiffany Companies’s CASI Pharmaceuticals CASI Stock Holding History

Kistler-Tiffany Companies’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-5	Closed	–	–	583
2014 Q1	$0	Hold	5	–	–	﹤0.01%	561
2013 Q4	$0	Hold	5	–	–	﹤0.01%	569
2013 Q3	$0	Hold	5	–	–	﹤0.01%	567
2013 Q2	$0	Buy	+5	New	+$97	﹤0.01%	582

Other funds holding CASI

WSCM

Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

WSC

Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Kistler-Tiffany Companies's CASI Position: Q2 2014 in Review

Kistler-Tiffany Companies sold out of CASI Pharmaceuticals (CASI) in Q2 2014, closing a stake of 5 shares.

Kistler-Tiffany Companies first reported a position in CASI in Q2 2013 and held it in 4 quarters. The position peaked at $0 in Q1 2014. 6 funds tracked by Wall St. Rank hold CASI as of Q2 2014.

Kistler-Tiffany Companies reported no remaining CASI Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
Kistler-Tiffany Companies sold 5 CASI Pharmaceuticals shares in Q2 2014.
Kistler-Tiffany Companies first reported a position in CASI Pharmaceuticals in Q2 2013 and held it in 4 quarters.
Kistler-Tiffany Companies's CASI Pharmaceuticals position peaked at $0 in Q1 2014.
6 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2014.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2014, filed 12 Aug 2014.